Bausch Health Companies (BHC) Debt Ratio (2009 - 2026)
Bausch Health Companies' (BHC) quarterly Debt Ratio came in at 0.87 in Q2 2026, up 5.06% year-over-year from 0.83 in Q2 2025, and down 1.4% quarter-over-quarter from 0.88 in Q1 2026.
Analysis
Bausch Health Companies (BHC) Debt Ratio (2009 - 2026) Analysis & Trends
Bausch Health Companies has disclosed Debt Ratio across 18 years of filings, most recently posting 0.87 for Q2 2026.
- In Q2 2026, Debt Ratio rose 5.06% year-over-year to 0.87; the TTM figure through Jun 2026 stood at 0.87 (up 5.06% YoY), while the FY2025 annual figure was 0.8, down 12.86% from the prior year.
- Debt Ratio came in at 0.87 for Q2 2026 at Bausch Health Companies, down from 0.88 in the prior quarter.
- In the past five years, Debt Ratio ranged from a high of 0.92 in Q4 2024 to a low of 0.78 in Q2 2022.
- Average Debt Ratio over 5 years is 0.83, with a median of 0.83 recorded in 2024.
- Year-over-year, Debt Ratio increased 9.67% in 2024 and slipped 12.86% in 2025.
- Over 5 years, Debt Ratio stood at 0.83 in 2022, then increased by 1.18% to 0.84 in 2023, then rose by 9.67% to 0.92 in 2024, then fell by 12.86% to 0.8 in 2025, then rose by 9.2% to 0.87 in 2026.
- Per Business Quant data, the three most recent Debt Ratio figures were 0.87 in Q2 2026, 0.88 in Q1 2026, and 0.8 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 0.42 |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 0.38 |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 0.13 |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 0.71 |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 0.87 |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 0.85 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 0.20 |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 0.35 |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 0.87 |
| Mar 31, 2026 | 0.88 |
| Dec 31, 2025 | 0.80 |
| Sep 30, 2025 | 0.81 |
| Jun 30, 2025 | 0.83 |
| Mar 31, 2025 | 0.82 |
| Dec 31, 2024 | 0.92 |
| Sep 30, 2024 | 0.83 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | 0.84 |
| Dec 31, 2023 | 0.84 |
| Sep 30, 2023 | 0.85 |
| Jun 30, 2023 | 0.82 |
| Mar 31, 2023 | 0.83 |
| Dec 31, 2022 | 0.83 |
| Sep 30, 2022 | 0.82 |
| Jun 30, 2022 | 0.78 |
| Mar 31, 2022 | 0.80 |
| Dec 31, 2021 | 0.78 |
| Sep 30, 2021 | 0.76 |